There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Experts warn Ozempic and Mounjaro may cause sudden, irreversible blindness as patients report vision loss after taking the weight loss drugs.

WEIGHT-loss jabs are taking the world by storm, with a staggering half a million of us now using them. The injections have ...

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

Drugs like Ozempic, Wegovy, and Mounjaro have demonstrated remarkable efficacy, not only in lowering blood sugar but also in facilitating substantial weight loss. Clinical trials show that ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

Actress and comedian Amy Schumer said she took Ozempic three years ago and quickly lost 30 lbs. However, she quit the ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Below is the number of times Wegovy, Ozempic, and Mounjaro has been prescribed in every former CCG area in Yorkshire. Number of times semaglutide was prescribed on average each month 2023/2024: 892 ...

Demand for weight loss jabs continues to surge and has been spurred on by the NHS offering Wegovy to patients and will start offering Mounjaro in March 2025. They have also become increasingly popular ...